Accessibility Help | Sitemap | Contact Us | Customer Support CALL 1300 524 822
Australia Change Country
Careers | Investor Relations | News & Media | Events | About KCI
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education & Training  |  For Patients  |  Customer Support

Welcome to KCI

Features

News   Medical Professionals   Patient Stories
KCI logo KCI Obtains Injunction against Smith & Nephew in United Kingdom
UK High Court of Justice Enters Injunction Against Smith & Nephew’s NPWT Products; Injunction Stayed Pending Expedited Appeal
Prevena Category New: Prevena™ Incision Management System
The first and only powered negative pressure product designed specifically for management of incisions at risk of postoperative complications.
Nigel Nigel’s Story
See how V.A.C.® Therapy helped a soldier win the fight against a terrible wound.
KCI logo KCI Boosts Research and Development Capabilities with Launch of Advanced Research and Technology Center
Innovation Center to Accelerate Company Mission of Making Healing Possible; New Organization Will Fuel Product Development and Commercialization
ABThera Logo New: ABThera™ Open Abdomen Negative Pressure Therapy System
A temporary abdominal closure system that enables healthcare professionals to take control early in the management of challenging open abdomens.

Advantage Centre - Knowledge to Better Care

Advanced theoretical and practical skills education to high level clinicians and hospital administrators from the public, private and community care settings.

About KCI

KCI is committed to advancing healing technology that positively impacts the lives of patients, their families, caregivers and providers alike.


Important Message for Patients

Legal Notice | Privacy Policy | Contact Us

Copyright © 1998 – 2010 KCI Licensing, Inc All Rights Reserved.   DSL# 09-03-193.AU

The information included in this Web site has been prepared for and is intended for viewing exclusively within Australia. This Web site contains information about products which may or may not be available in different countries and if applicable,may or may not have received approval or market clearance by a governmental regulatory body for different indications and restriction in different countries.